Zantac Alternative Medicines May Increase The Risk of Contracting The Coronavirus

A new study links protein pump blockers (PPI) with an increased risk of developing COVID19

Wednesday, July 8, 2020 - Individuals have been filing lawsuits alleging that there is a link between taking Zantac (ranitidine) and developing cancer of the stomach, bladder, prostate, and many other forms of cancer. Zantac is the world's best-selling brand of ranitidine and could contain dangerously high levels of N-Nitrosodimethylamine (NDMA), a carcinogen and a by-product of manufacturing rocket fuel and given to laboratory test animals to induce tumors. Zantac was recalled by both Sanofi, the drug's manufacturer, and the FDA forcing heartburn and antacid sufferers to look to their physicians to recommend a safe alternative to fight indigestion. The US Food and Drug Administrations advised physicians to advise their patients to choose from several drugs that could replace Zantac. The agency has tested several they found to be safe and NDMA-free. "FDA testing to date has not found NDMA in famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (Nexium), lansoprazole (Prevacid), or omeprazole (Prilosec)." These drugs, however, may have other serious risks, and a recent study links these protein pump inhibitors (PPI) to individuals with an increased risk of contracting COVID 19. Proton pump inhibitors (PPIs) work by permanently blocking specific enzymes from secreting acid into the stomach. Zantac stomach cancer lawyers have vast experience with medical litigation and offer a free consultation with no obligation to file a claim.

According to Time Magazine, a study published by the American Journal of Gastroenterology released yesterday indicated that certain acid reflux and heartburn drugs classified as Protein Pump Inhibitors increase the risk or getting the Coronavirus. The study consisting of nearly 90,000 asked participants if they were suffering from heartburn or acid reflux and if so, what medicine had they been taking. Of the 86,000 people in the test sample, 53,000 reported the condition above. Over 3,300 tested positive for COVID19 and were taking proton pump inhibitor (PPI) medications such as Pepcid, Prilosec, or Prevacid presumably as a replacement for the recalled Zantac. The study consisted of an online survey conducted by Dr. Brennan Spiegel who was not surprised by the results, knowing what he does about the side effects of PPI drugs. Time reports, "Previous studies have found that people taking PPI medications can be at higher risk of certain infections, including C.difficile (common in hospitals). That's because the drugs reduce stomach acid, and acid is one way the body kills off potentially harmful bacteria and viruses. "

Hundreds of lawsuits have been filed that allege that Sanofi, the maker of Zantac, knew or should have known about the potential cancer link with NDMA or should have known and failed to warn consumers for over a decade. The company earned billions of dollars per year selling the antacid. The most recent lawsuit was filed by Kentucky resident Aaron Hayden who alleges that high levels of NDMA in Zantac he ingested between the years of 2014 and 2017 caused his bladder cancer. About Lawsuits.com reports, "The lawsuit presents claims against various manufacturers of Zantac, including Boehringer Ingelheim, Sanofi US Services, Chattem, Inc., Pfizer, and GlaxoSmithKline, indicating that the drug makers knew or should have known that the Zantac ingredient is inherently dangerous and unsafe when ingested."

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.